[{"indications": "Indications\u00a0leprosy", "name": "CLOFAZIMINE", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "5 Infections", "5.1 Antibacterial drugs", "5.1.10 Antileprotic drugs"], "cautions": "Cautions\u00a0may discolour soft contact lenses; avoid if persistent abdominal pain and diarrhoea", "side-effects": "Side-effects\u00a0nausea, vomiting (hospitalise if persistent),\r\nabdominal pain; headache, tiredness; brownish-black discoloration\r\nof lesions and skin including areas exposed to light; reversible hair\r\ndiscoloration; dry skin; red discoloration of faeces, urine and other\r\nbody fluids; also rash, pruritus, photosensitivity, acne-like eruptions,\r\nanorexia, eosinophilic enteropathy, bowel obstruction, dry eyes, dimmed\r\nvision, macular and subepithelial corneal pigmentation; elevation\r\nof blood sugar, weight loss, splenic infarction, lymphadenopathy", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/3928.htm", "doses": ["Leprosy, see notes above", "Lepromatous lepra reactions, dosage increased to 300\u00a0mg daily\r\nfor max. of 3 months"], "pregnancy": "Pregnancy\u00a0use with caution"}]